Atıf İçin Kopyala
Kır S., Ekiz K., Alacam H., Turkel R., Koroglu E., Altintop B. L.
ACTA ENDOCRINOLOGICA-BUCHAREST, cilt.15, sa.4, ss.430-435, 2019 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
15
Sayı:
4
-
Basım Tarihi:
2019
-
Doi Numarası:
10.4183/aeb.2019.430
-
Dergi Adı:
ACTA ENDOCRINOLOGICA-BUCHAREST
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.430-435
-
Anahtar Kelimeler:
Metabolic syndrome, inflammatory markers, abdominal obesity, hypertension, hyperglycemia, hypertriglyceridemia, TUMOR-NECROSIS-FACTOR, ADIPOSE-TISSUE, INSULIN ACTION, ADHESION MOLECULES, ALPHA LEVELS, TNF-ALPHA, ADIPONECTIN, INTERLEUKIN-6, INFLAMMATION, OBESE
-
Ondokuz Mayıs Üniversitesi Adresli:
Evet
Özet
Objectives. Metabolic syndrome (MetS) is a cluster of metabolic abnormalities that is linked with increased circulating markers of oxidative stress and low-grade inflammation. The link between inflammation and MetS is not yet fully understood. We aim to evaluate the relationship between the levels of pro and anti-inflammatory markers such as apolipoprotein A1 (Apo-A1), apolipoprotein B (Apo-B), interleukin (IL) 6, tumor necrosis factor alpha (TNF-alpha), fibrinogen and complement component 3 (C3) and adiponectin and MetS/MetS components.